FDA Inspection 1267709 — Eurofins Pharmaceutical Product Testing Belgium NV
The FDA completed an inspection of Eurofins Pharmaceutical Product Testing Belgium NV on March 21, 2025 in Nazareth. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nazareth (Belgium)